ClinicalTrials.gg
Enrolling by invitationNCT06283953BREATHEUpdated Nov 18, 2026

Boosting Resources for Tracheostomy Care at Home

An interventional study of Trach Plus and Trach Me Home in Tracheostomy and Caregiver Burden, sponsored by Massachusetts General Hospital. Enrolling by invitation at 6 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by Massachusetts General Hospital · Not applicable, Interventional, and Health services research

How we know

Updated Nov 18, 2026Primary completion movedStudy completion moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
330
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 10 studies in Caregiver Burden by Massachusetts General Hospital — 3 open to participants now, 3 under way, none of them phase 3. Caregiver Burden · Massachusetts General Hospital.

Planned enrollment
2nd of 10
330 · median 108
Started
2024
with 3 others
No phase
10 of 10
3 open now
Registered
9th of 10
by date

Among the 10 studies in Caregiver Burden by Massachusetts General Hospital, this one is the 2nd largest by planned enrollment, is one of 4 that started in 2024, is one of 10 with no phase, and was the 9th registered.

Caregiver Burden

503 studies on the registry are indexed under Caregiver Burden; 166 are open to participants now.

Browse Caregiver Burden studies →

Open to participants now

3 of the 10 studies in Caregiver Burden by Massachusetts General Hospital are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 3 open studies →

Where they have run

Who these studies take

Of the 90 Caregiver Burden studies recruiting now, 69 (77%) set no upper age limit and 7 (8%) stop at 75 or younger; 8 take children under 18; 39 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Caregiver Burden by Massachusetts General Hospital, or all of them as a file.
02

Study summary

The goal of this trial is to advance the understanding of how to best support caregivers of children with tracheostomies who are caring for their child at home. The main questions it aims to answer are:

  • What are the best ways to support caregivers post-discharge with both medical and nonmedical decisions about resuming life, work, and family activities, while safely caring for their child with a tracheostomy at home?
  • How can the investigators leverage existing technology to facilitate communication between inpatient and outpatient care teams to better support needs of pediatric patients and caregivers post-discharge?

Caregiver participants will be randomly assigned to receive Trach Me Home (gold standard discharge program) or Trach Me Home with additional components. Caregiver participants will complete three surveys over the course of 6 months. Researchers will see if caregivers in the Trach Me Home with additional components report lower caregiver burden at 4 weeks post discharge (primary outcome) and fewer hospital readmissions at 6 months than those in Trach Me Home arm.

Read the detailed description

The study is focused on a rare and medically complex population of children with tracheostomies. The study is a Type I hybrid effectiveness-implementation study using a pragmatic randomized trial at six participating sites. The goal of this trial is to advance the understanding of how to best support caregivers of children with tracheostomies who are caring for their child at home. The main question[s] it aims to answer are:

  • What are the best ways to support caregivers post-discharge with both medical and nonmedical decisions about resuming life, work, and family activities, while safely caring for their child with a tracheostomy at home?
  • How can the investigators leverage existing technology to facilitate communication between inpatient and outpatient care teams to better support needs of pediatric patients and caregivers post-discharge?

Caregiver participants will randomly assigned to the Comparator arm (gold standard discharge program) or to the Intervention arm (gold standard program with other components). Caregiver participants will complete three surveys over the course of 6 months. The investigators will test two main hypotheses: the Intervention arm will have (1) significantly lower caregiver burden at 4 weeks post discharge (primary outcome) and (2) significantly lower readmissions or emergency room visits at 6 months post discharge than the Comparator arm.

The investigators will also survey pediatricians of participating patients at 6 months post discharge and examine whether intervention arm pediatricians have higher satisfaction with discharge communication than those in comparator arm.

03

Conditions studied

  • Tracheostomy
  • Caregiver Burden

Browse trials for

Keywords

  • shared decision making
  • patient reported outcomes
  • tracheostomy
  • ventilator
  • caregiver
  • discharge program
  • pediatric
04

Who can participate

The criteria were revised on the registry on Nov 18, 2026. See what changed

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Lead or primary adult caregiver (18 or older) of infants or children (0-18 years old) with tracheostomy who are planning for discharge to home, including children who are dependent on ventilator

Exclusion criteria

Exclusion Criteria:

  • Patients transferred to other hospital or facility (and/or not discharged to home during study period)
  • Primary caregiver unable to read or write in English, Spanish, Mandarin, or Arabic
  • Not residing in the U.S. for at least 12 months after discharge
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
330 participants (estimated)

Study arms

  • Active comparator
    Active Comparator Caregivers

    TrachMeHome program delivered in the hospital including education, skills training and case management for caregivers

    Behavioral: Trach Me Home

  • Experimental
    Intervention Caregivers

    Trach Me Home and Trach Plus with additional education, outpatient care team communication and social support for caregivers.

    Behavioral: Trach Plus · Behavioral: Trach Me Home

  • Active comparator
    Active Comparator Physicians

    Primary care physicians' of the enrolled participant's child receiving discharge communication

    Behavioral: Trach Me Home

  • Experimental
    Intervention Physicians

    Primary care physicians' of the enrolled participant's child receiving outpatient care team communication prior to discharge

    Behavioral: Trach Plus · Behavioral: Trach Me Home

Interventions

  • BehavioralTrach Plus

    The Trach Plus program includes education, social support, and outreach to outpatient care team.

  • BehavioralTrach Me Home

    The Trach Me Home discharge program includes caregiver education, skills training and case management.

06

What researchers measure

Primary outcomes

  1. Caregiver Burden

    Pediatric Tracheostomy Health Status Instrument (PTHSI) Caregiver burden subscale, total scores range from 0-68. Higher scores indicate higher burden.

    Time frame: 4 weeks post-discharge

Secondary outcomes

  1. Medical Complications Associated with Tracheostomy

    4-item modified Medical Complications Associated with Tracheostomy (MCAT) measure that includes 4 caregiver reported items to assess the total number of urgent medical visits, emergency room and readmissions for tracheostomy-related issues. Items are summed and scores start at 0 and there is no upper limit. Higher total numbers are worse.

    Time frame: 6 months post-discharge

  2. 6-month Readmission Rate

    Percentage with one or more emergency room visits or hospital readmissions as documented in the electronic health record within 6 months of discharge.

    Time frame: 6 months post-discharge

  3. Frequency of pediatrician communication

    Percentage of pediatrician-specific communication with inpatient team prior to and/or shortly after discharge documented in electronic medical record or by pediatrician report.

    Time frame: 6 months post-discharge

  4. Primary care pediatrician satisfaction

    Clinician reported satisfaction with discharge communication scored from 0-100, higher scores indicate higher satisfaction with discharge communication.

    Time frame: 6 months post-discharge

  5. Medical Complications Associated with Tracheostomy

    4-item modified Medical Complications Associated with Tracheostomy (MCAT) measure that includes 4 caregiver reported items to assess the total number of urgent medical visits, emergency room and readmissions for tracheostomy-related issues. Items are summed and scores start at 0 and there is no upper limit. Higher total numbers are worse.

    Time frame: 4 weeks post-discharge

  6. Caregiver Burden

    Pediatric Tracheostomy Health Status Instrument (PTHSI) Caregiver burden subscale, total scores range from 0-68. Higher scores indicate higher burden.

    Time frame: 6 months post-discharge

Other outcomes

  1. Number of readmissions

    The total number of electronic health record documented emergency room visits and hospital admissions will be collected, with higher numbers being worse (indicating more readmissions).

    Time frame: 6 months post discharge

07

Study locations

6 sites
08

References and documents

Publications

  • Sepucha K, Callans K, Leavitt L, Chang Y, Vo H, Brigger M, Broughton S, Cahill J, Chinnadurai S, Germann J, Giordano T, Greenlick-Michals H, Javia L, Jayawardena ADL, Osthimer J, Patel RC, Redmann A, Roumiantsev S, Simmons L, Smith M, Tate M, Warren M, Whalen K, Yager P, Zalzal H, Hartnick C. Boosting REsources And caregiver empowerment for Tracheostomy care at HomE (BREATHE) Study: study protocol for a stratified randomization trial. Trials. 2024 Oct 28;25(1):722. doi: 10.1186/s13063-024-08522-x. PubMed 39468582 ↗

Individual participant data

Plan to share: Yes — To promote research replicability, transparency and future use of the data, de-identified data sets will be created and will be available, by request, to outside researchers. The Data Package (comprised of the de-identified Analyzable Data Set, Full Protocol, metadata, data dictionary, full statistical analysis plan, and analytic code from the project) will be deposited in the Patient-Centered Outcomes Research Institute's Data Repository at the ICPSR. Participant information sheets for the study will indicate that de-identified information will be deposited in an open access service to promote use of the data by other researchers. No information that contains identifiers or that could be used to link an individual to the data will be included in the de-identified data set. No data will be provided from qualitative transcripts as this may lead to identifying information about participants. However, codes abstracted from qualitative transcripts may be made available.

Supporting information: Study protocol, Statistical analysis plan, Analytic code

Time frame: After study results have been published, about 1 year after the end of the funded grant period, the study materials and de-identified data will be placed on an open access service such as ICPSR where they will be available indefinitely.

Access criteria: Researchers may access the data through the PCORI-designated repository (ICPSR's website) once it is made available.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2024 (actual). Primary completion is estimated for Jun 2027, 36 months after the start.

Of 285 non-industry interventional studies with no phase under Caregiver Burden, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 31. This study's planned 36 months is above that.

Counting every sponsor, half of 294 studies reached it within 16 months; a quarter within 7 and three quarters within 31.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 18, 2026: primary completion Dec 2026 → Jun 2027 and completion Oct 2027 → Apr 2028.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Feb 21, 2024
First posted
Feb 28, 2024
StartActual
May 16, 2024
Primary completionEst.
Jun 1, 2027was Dec 2026
CompletionEst.
Apr 1, 2028was Oct 2027
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Dec 1, 2026→Jun 1, 2027
Nov 18, 2026
Study completion
Oct 1, 2027→Apr 1, 2028
Nov 18, 2026
Enrollment
480→330
Nov 18, 2026
Eligibility
1 inclusion criterion edited
What changed in the criteria
Inclusion criteria
  • EditedLead or primary adult caregiver (18 or older) of infants or children (0-1718 years old) with tracheostomy who are planning for discharge to home, including children who are dependent on ventilator
Nov 18, 2026
Show all 2 updates
  1. Nov 18, 2026
    Primary completion Dec 1, 2026→Jun 1, 2027
    Study completion Oct 1, 2027→Apr 1, 2028
    Enrollment 480→330
    Eligibility 1 inclusion criterion edited
    What changed in the criteria
    Inclusion criteria
    • EditedLead or primary adult caregiver (18 or older) of infants or children (0-1718 years old) with tracheostomy who are planning for discharge to home, including children who are dependent on ventilator
    + 1 other change: verification date
  2. Sep 30, 2026
    Minor edits only
    + 2 other changes: verification date and oversight details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06283953
Collaborators
Children's Hospital Medical Center, Cincinnati, Children's Hospital of Philadelphia, Children's Hospitals and Clinics of Minnesota, Children's National Research Institute, Rady Children's Hospital, San Diego, Patient-Centered Outcomes Research Institute
Responsible party
Karen Sepucha (Associate Professor, Massachusetts General Hospital) — Principal investigator
First posted
Feb 28, 2024
Start date
May 16, 2024
Primary completion
Jun 1, 2027 (estimated)
Completion
Apr 1, 2028 (estimated)
Last update
Nov 18, 2026

Study contacts

Karen Sepucha, PhD
principal investigator · Massachusetts General Hospital
Christopher Hartnick, MD
principal investigator · Massachusetts Eye and Ear Infirmary / Massachusetts General Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion